Barclays’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.7K | Sell |
6,507
-925
| -12% | -$10.8K | ﹤0.01% | 4261 |
|
|
2025
Q4 | $111K | Buy |
7,432
+6,024
| +428% | +$105K | ﹤0.01% | 4554 |
|
|
2025
Q3 | $27.1K | Buy |
+1,408
| New | +$22.5K | ﹤0.01% | 4894 |
|
|
2025
Q2 | – | Sell |
-80
| Closed | -$1.11K | – | 5431 |
|
|
2025
Q1 | $1.11K | Hold |
80
| – | – | ﹤0.01% | 5042 |
|
|
2024
Q4 | $1.32K | Hold |
80
| – | – | ﹤0.01% | 5132 |
|
|
2024
Q3 | $1.51K | Sell |
80
-23
| -22% | -$467 | ﹤0.01% | 5102 |
|
|
2024
Q2 | $1.49K | Sell |
103
-3,435
| -97% | -$57.3K | ﹤0.01% | 4663 |
|
|
2024
Q1 | $54.8K | Sell |
3,538
-3,221
| -48% | -$69.5K | ﹤0.01% | 4600 |
|
|
2023
Q4 | $189K | Sell |
6,759
-16,301
| -71% | -$428K | ﹤0.01% | 4443 |
|
|
2023
Q3 | $1.1M | Buy |
23,060
+4,515
| +24% | +$345K | ﹤0.01% | 2267 |
|
|
2023
Q2 | $1.78M | Buy |
18,545
+13,042
| +237% | +$1.42M | ﹤0.01% | 1961 |
|
|
2023
Q1 | $624K | Sell |
5,503
-3,330
| -38% | -$360K | ﹤0.01% | 3114 |
|
|
2022
Q4 | $989K | Buy |
8,833
+954
| +12% | +$128K | ﹤0.01% | 2808 |
|
|
2022
Q3 | $1.01M | Buy |
7,879
+5,955
| +310% | +$610K | ﹤0.01% | 2224 |
|
|
2022
Q2 | $132K | Buy |
1,924
+992
| +106% | +$85.5K | ﹤0.01% | 3654 |
|
|
2022
Q1 | $132K | Sell |
932
-12,153
| -93% | -$1.87M | ﹤0.01% | 3658 |
|
|
2021
Q4 | $2.18M | Buy |
13,085
+10,688
| +446% | +$1.7M | ﹤0.01% | 2333 |
|
|
2021
Q3 | $334K | Buy |
2,397
+1,179
| +97% | +$231K | ﹤0.01% | 3374 |
|
|
2021
Q2 | $582K | Sell |
1,218
-1,533
| -56% | -$647K | ﹤0.01% | 2994 |
|
|
2021
Q1 | $1.13M | Buy |
2,751
+1,569
| +133% | +$722K | ﹤0.01% | 2692 |
|
|
2020
Q4 | $578K | Sell |
1,182
-339
| -22% | -$199K | ﹤0.01% | 3154 |
|
|
2020
Q3 | $862K | Buy |
1,521
+111
| +8% | +$36.9K | ﹤0.01% | 2815 |
|
|
2020
Q2 | $135K | Buy |
1,410
+804
| +133% | +$70.5K | ﹤0.01% | 4340 |
|
|
2020
Q1 | $43K | Sell |
606
-1,221
| -67% | -$81.9K | ﹤0.01% | 5314 |
|
|
2019
Q4 | $126K | Buy |
1,827
+840
| +85% | +$62.3K | ﹤0.01% | 5341 |
|
|
2019
Q3 | $79K | Buy |
987
+264
| +37% | +$17.4K | ﹤0.01% | 5649 |
|
|
2019
Q2 | $47K | Buy |
723
+409
| +130% | +$38.8K | ﹤0.01% | 6127 |
|
|
2019
Q1 | $43K | Buy |
314
+303
| +2,755% | +$36.9K | ﹤0.01% | 5987 |
|
|
2018
Q4 | $1K | Sell |
11
-382
| -97% | -$53.5K | ﹤0.01% | 6813 |
|
|
2018
Q3 | $60K | Buy |
393
+278
| +242% | +$45K | ﹤0.01% | 5962 |
|
|
2018
Q2 | $20K | Sell |
115
-264
| -70% | -$43.1K | ﹤0.01% | 6190 |
|
|
2018
Q1 | $56K | Sell |
379
-1,183
| -76% | -$227K | ﹤0.01% | 5828 |
|
|
2017
Q4 | $317K | Sell |
1,562
-570
| -27% | -$117K | ﹤0.01% | 4285 |
|
|
2017
Q3 | $684K | Buy |
2,132
+1,370
| +180% | +$374K | ﹤0.01% | 3331 |
|
|
2017
Q2 | $173K | Sell |
762
-985
| -56% | -$202K | ﹤0.01% | 4489 |
|
|
2017
Q1 | $393K | Buy |
1,747
+1,545
| +765% | +$314K | ﹤0.01% | 3648 |
|
|
2016
Q4 | $40K | Sell |
202
-183
| -48% | -$39.9K | ﹤0.01% | 5299 |
|
|
2016
Q3 | $94K | Buy |
385
+355
| +1,183% | +$125K | ﹤0.01% | 4551 |
|
|
2016
Q2 | $18K | Buy |
30
+20
| +200% | +$11.7K | ﹤0.01% | 5317 |
|
|
2016
Q1 | $5K | Sell |
10
-26
| -72% | -$13.6K | ﹤0.01% | 5675 |
|
|
2015
Q4 | $25K | Buy |
+36
| New | +$23.7K | ﹤0.01% | 5119 |
|
Other funds holding MCRB
FP
VCM
VFT
